Genmab(DE:GE91)
€46.00-0.60 (-1.29%)
DE:GE91
Genmab earnings date
€46.00
At close:-0.60 (-1.29%)
Genmab (GE91) Q3 2018 Earnings Report
3 Followers
DE:GE91 Q3 2018 EPS Results
- Actual EPS
- EUR 0.04
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- EUR 0.00
DE:GE91 Q3 2018 Revenue Results
- Actual Revenue
- EUR 84.96M
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q3 2018
- Date
- 11/14/2018
- Time
- During Market Hours
- Conference Call
- Wednesday, November 14, 2018
DE:GE91 Upcoming Earnings
Genmab's next earnings date is estimated for February 24, 2027, based on past reporting schedules.
Q3 2018 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2018 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2018 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:GE91 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 24, 2027 | 2026 (Q4) | 0.19- | 0.05 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | 0.320.50 | 0.59 | -14.71% (-0.09) | |
| Aug 06, 2026 | 2026 (Q2) | 0.320.45 | 0.49 | -9.41% (-0.05) | |
| May 07, 2026 | 2026 (Q1) | 0.140.08 | 0.28 | -72.79% (-0.20) | |
| Feb 17, 2026 | 2025 (Q4) | 0.260.05 | 0.77 | -94.12% (-0.73) | |
| Nov 10, 2025 | 2025 (Q3) | 0.440.59 | 0.26 | 125.09% (+0.33) | |
| Aug 07, 2025 | 2025 (Q2) | 0.360.49 | 0.29 | 70.98% (+0.20) | |
| May 08, 2025 | 2025 (Q1) | 0.210.28 | 0.27 | 4.45% (+0.01) | |
| Feb 12, 2025 | 2024 (Q4) | 0.340.77 | 0.13 | 512.23% (+0.65) | |
| Nov 06, 2024 | 2024 (Q3) | 0.280.26 | 0.42 | -38.15% (-0.16) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

